In a recently published Phase III clinical trial, injection of AAV2 vectors containing a functional copy of the RPE65 gene into the retinas of LCA patients with biallelic RPE65 mutations resulted in partial restoration of scotopic visual function.13 The gene discussed is RPE65; the disease is Leber congenital amaurosis.